URACIL MUSTARD (nda012892)- (1MG)

Generic Name	URACIL MUSTARD	Innovator	SHIRE
Dosage	1MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	URACIL MUSTARD is indicated for: *Chronic Lymphocytic Leukemia *Non-Hodgkin's Leukemic * Chromic Myelogenous Leukemic and other condition like Polycythemia vera, mycosis fungoides.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
1MG	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of URACIL MUSTARD